214 related articles for article (PubMed ID: 25727309)
1. Characterizing the mechanism of thiazolidinedione-induced hepatotoxicity: An in vitro model in mitochondria.
Hu D; Wu CQ; Li ZJ; Liu Y; Fan X; Wang QJ; Ding RG
Toxicol Appl Pharmacol; 2015 Apr; 284(2):134-41. PubMed ID: 25727309
[TBL] [Abstract][Full Text] [Related]
2. Troglitazone-induced hepatic necrosis in an animal model of silent genetic mitochondrial abnormalities.
Ong MM; Latchoumycandane C; Boelsterli UA
Toxicol Sci; 2007 May; 97(1):205-13. PubMed ID: 17150972
[TBL] [Abstract][Full Text] [Related]
3. Increased susceptibility to troglitazone-induced mitochondrial permeability transition in type 2 diabetes mellitus model rat.
Segawa M; Sekine S; Sato T; Ito K
J Toxicol Sci; 2018; 43(5):339-351. PubMed ID: 29743445
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial permeability transition as a potential determinant of hepatotoxicity of antidiabetic thiazolidinediones.
Masubuchi Y; Kano S; Horie T
Toxicology; 2006 May; 222(3):233-9. PubMed ID: 16621215
[TBL] [Abstract][Full Text] [Related]
5. Troglitazone hepatotoxicity: are we getting closer to understanding idiosyncratic liver injury?
Jaeschke H
Toxicol Sci; 2007 May; 97(1):1-3. PubMed ID: 17575588
[No Abstract] [Full Text] [Related]
6. The thiazolidinedione pioglitazone alters mitochondrial function in human neuron-like cells.
Ghosh S; Patel N; Rahn D; McAllister J; Sadeghi S; Horwitz G; Berry D; Wang KX; Swerdlow RH
Mol Pharmacol; 2007 Jun; 71(6):1695-702. PubMed ID: 17387142
[TBL] [Abstract][Full Text] [Related]
7. Thiazolidinedione bioactivation: a comparison of the bioactivation potentials of troglitazone, rosiglitazone, and pioglitazone using stable isotope-labeled analogues and liquid chromatography tandem mass spectrometry.
Alvarez-Sanchez R; Montavon F; Hartung T; Pähler A
Chem Res Toxicol; 2006 Aug; 19(8):1106-16. PubMed ID: 16918252
[TBL] [Abstract][Full Text] [Related]
8. Multiple mechanisms underlying troglitazone-induced mitochondrial permeability transition.
Okuda T; Norioka M; Shitara Y; Horie T
Toxicol Appl Pharmacol; 2010 Nov; 248(3):242-8. PubMed ID: 20709092
[TBL] [Abstract][Full Text] [Related]
9. Hydrogen peroxide overproduction in megamitochondria of troglitazone-treated human hepatocytes.
Shishido S; Koga H; Harada M; Kumemura H; Hanada S; Taniguchi E; Kumashiro R; Ohira H; Sato Y; Namba M; Ueno T; Sata M
Hepatology; 2003 Jan; 37(1):136-47. PubMed ID: 12500198
[TBL] [Abstract][Full Text] [Related]
10. The mitochondrial superoxide/thioredoxin-2/Ask1 signaling pathway is critically involved in troglitazone-induced cell injury to human hepatocytes.
Lim PL; Liu J; Go ML; Boelsterli UA
Toxicol Sci; 2008 Feb; 101(2):341-9. PubMed ID: 17975114
[TBL] [Abstract][Full Text] [Related]
11. Integrative toxicoproteomics implicates impaired mitochondrial glutathione import as an off-target effect of troglitazone.
Lee YH; Goh WW; Ng CK; Raida M; Wong L; Lin Q; Boelsterli UA; Chung MC
J Proteome Res; 2013 Jun; 12(6):2933-45. PubMed ID: 23659346
[TBL] [Abstract][Full Text] [Related]
12. Differentiating members of the thiazolidinedione class: a focus on safety.
Lebovitz HE
Diabetes Metab Res Rev; 2002; 18 Suppl 2():S23-9. PubMed ID: 11921435
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the role of the thiazolidinedione ring of troglitazone in inducing hepatotoxicity.
Saha S; New LS; Ho HK; Chui WK; Chan EC
Toxicol Lett; 2010 Feb; 192(2):141-9. PubMed ID: 19854250
[TBL] [Abstract][Full Text] [Related]
14. Toxicity of Pioglitazone on Mitochondria Isolated from Brain and Heart: An Analysis for Probable Drug-Induced Neurotoxicity and Cardiotoxicity.
Seydi E; Servati T; Samiei F; Naserzadeh P; Pourahmad J
Drug Res (Stuttg); 2020 Feb; 70(2-03):112-118. PubMed ID: 31931547
[TBL] [Abstract][Full Text] [Related]
15. Ionizing radiation induces mitochondrial reactive oxygen species production accompanied by upregulation of mitochondrial electron transport chain function and mitochondrial content under control of the cell cycle checkpoint.
Yamamori T; Yasui H; Yamazumi M; Wada Y; Nakamura Y; Nakamura H; Inanami O
Free Radic Biol Med; 2012 Jul; 53(2):260-70. PubMed ID: 22580337
[TBL] [Abstract][Full Text] [Related]
16. Troglitazone-induced intracellular oxidative stress in rat hepatoma cells: a flow cytometric assessment.
Narayanan PK; Hart T; Elcock F; Zhang C; Hahn L; McFarland D; Schwartz L; Morgan DG; Bugelski P
Cytometry A; 2003 Mar; 52(1):28-35. PubMed ID: 12596249
[TBL] [Abstract][Full Text] [Related]
17. Troglitazone, but not rosiglitazone, damages mitochondrial DNA and induces mitochondrial dysfunction and cell death in human hepatocytes.
Rachek LI; Yuzefovych LV; Ledoux SP; Julie NL; Wilson GL
Toxicol Appl Pharmacol; 2009 Nov; 240(3):348-54. PubMed ID: 19632256
[TBL] [Abstract][Full Text] [Related]
18. Troglitazone Stimulates Cancer Cell Uptake of 18F-FDG by Suppressing Mitochondrial Respiration and Augments Sensitivity to Glucose Restriction.
Moon SH; Lee SJ; Jung KH; Quach CH; Park JW; Lee JH; Cho YS; Lee KH
J Nucl Med; 2016 Jan; 57(1):129-35. PubMed ID: 26449833
[TBL] [Abstract][Full Text] [Related]
19. Effect of thiazolidinediones on bile acid transport in rat liver.
Snow KL; Moseley RH
Life Sci; 2007 Jan; 80(8):732-40. PubMed ID: 17126857
[TBL] [Abstract][Full Text] [Related]
20. Role of mitogen-activated protein kinase (MAPK) in troglitazone-induced osteoblastic cell death.
Jung JY; Yoo CI; Kim HT; Kwon CH; Park JY; Kim YK
Toxicology; 2007 May; 234(1-2):73-82. PubMed ID: 17363128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
